BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19555072)

  • 21. A gadolinium(III) complex of a carboxylic-phosphorus acid derivative of diethylenetriamine covalently bound to inulin, a potential macromolecular MRI contrast agent.
    Lebdusková P; Kotek J; Hermann P; Vander Elst L; Muller RN; Lukes I; Peters JA
    Bioconjug Chem; 2004; 15(4):881-9. PubMed ID: 15264877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Avidin-dendrimer-(1B4M-Gd)(254): a tumor-targeting therapeutic agent for gadolinium neutron capture therapy of intraperitoneal disseminated tumor which can be monitored by MRI.
    Kobayashi H; Kawamoto S; Saga T; Sato N; Ishimori T; Konishi J; Ono K; Togashi K; Brechbiel MW
    Bioconjug Chem; 2001; 12(4):587-93. PubMed ID: 11459464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and relaxometry of high-generation (G = 5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates.
    Bryant LH; Brechbiel MW; Wu C; Bulte JW; Herynek V; Frank JA
    J Magn Reson Imaging; 1999 Feb; 9(2):348-52. PubMed ID: 10077036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the macromolecular MR contrast agents with ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer.
    Kobayashi H; Sato N; Kawamoto S; Saga T; Hiraga A; Haque TL; Ishimori T; Konishi J; Togashi K; Brechbiel MW
    Bioconjug Chem; 2001; 12(1):100-7. PubMed ID: 11170372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.
    Unger EC; Shen D; Wu G; Stewart L; Matsunaga TO; Trouard TP
    MAGMA; 1999 Aug; 8(3):154-62. PubMed ID: 10504042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vivo evaluation of a PAMAM-cystamine-(Gd-DO3A) conjugate as a biodegradable macromolecular MRI contrast agent.
    Xu R; Wang Y; Wang X; Jeong EK; Parker DL; Lu ZR
    Exp Biol Med (Maywood); 2007 Sep; 232(8):1081-9. PubMed ID: 17720954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of Chiral Dendrimer-Triamine-Coordinated Gd-MRI Contrast Agents Evaluated by in Vivo MRI and Estimated by in Vitro QCM.
    Miyake Y; Ishikawa S; Kimura Y; Son A; Imai H; Matsuda T; Yamada H; Toshimitsu A; Kondo T
    Sensors (Basel); 2015 Dec; 15(12):31973-86. PubMed ID: 26694418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Encapsulation of gadolinium ferrite nanoparticle in generation 4.5 poly(amidoamine) dendrimer for cancer theranostics applications using low frequency alternating magnetic field.
    Mekonnen TW; Birhan YS; Andrgie AT; Hanurry EY; Darge HF; Chou HY; Lai JY; Tsai HC; Yang JM; Chang YH
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110531. PubMed ID: 31590053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multinuclear MR characterization of a new hepatobiliary contrast agent. Preliminary results.
    Vander Elst L; Maton F; Laurent S; Seghi F; Muller RN
    Acta Radiol Suppl; 1997; 412():135-8. PubMed ID: 9240092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel intravascular macromolecular MRI contrast agent with generation-4 polyamidoamine dendrimer core: accelerated renal excretion with coinjection of lysine.
    Kobayashi H; Sato N; Kawamoto S; Saga T; Hiraga A; Ishimori T; Konishi J; Togashi K; Brechbiel MW
    Magn Reson Med; 2001 Sep; 46(3):457-64. PubMed ID: 11550236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biodegradable polydisulfide dendrimer nanoclusters as MRI contrast agents.
    Huang CH; Nwe K; Al Zaki A; Brechbiel MW; Tsourkas A
    ACS Nano; 2012 Nov; 6(11):9416-24. PubMed ID: 23098069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging.
    Gündüz S; Savić T; Toljić Đ; Angelovski G
    J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DTPA-bisamide-based MR sensor agents for peroxidase imaging.
    Querol M; Chen JW; Weissleder R; Bogdanov A
    Org Lett; 2005 Apr; 7(9):1719-22. PubMed ID: 15844889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic and in vivo evaluation of a self-assembled gadolinium(III)-iron(II) contrast agent with high relaxivity.
    Parac-Vogt TN; Vander Elst L; Kimpe K; Laurent S; Burtéa C; Chen F; Van Deun R; Ni Y; Muller RN; Binnemans K
    Contrast Media Mol Imaging; 2006; 1(6):267-78. PubMed ID: 17191767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat.
    Shuter B; Tofts PS; Wang SC; Pope JM
    Magn Reson Imaging; 1996; 14(3):243-53. PubMed ID: 8725190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-assembling DNA quadruplex conjugated to MRI contrast agents.
    Cai J; Shapiro EM; Hamilton AD
    Bioconjug Chem; 2009 Feb; 20(2):205-8. PubMed ID: 19125646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor.
    Wiener EC; Konda S; Shadron A; Brechbiel M; Gansow O
    Invest Radiol; 1997 Dec; 32(12):748-54. PubMed ID: 9406015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics.
    Burai L; Tóth E; Sour A; Merbach AE
    Inorg Chem; 2005 May; 44(10):3561-8. PubMed ID: 15877439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
    Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF
    Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.